GlobalRPh Renal Dosing Masterv6.6
GlobalRPh source record

Ampicillin/Sulbactam

ampicillin sulbactam / Unasyn

READ THE SOURCE-SPECIFIC ANSWER

Renal guidance at a glance

Cautions / source differences (2)

Confirm the product, indication and renal measure. The selected summary is not a complete prescribing monograph.

Choose a source to read (4)

Display order is not a clinical ranking. Date of retrieval is not the label revision date. Sources are never merged into one regimen. Other sources and conflicts remain below.

2 additional source qualifications - review before use
UNASYN label and UCSF do not use identical renal bands

At the printed value 30, the RX label table places patients in its at-least-30 row, whereas UCSF standard dosing places 30 in its 15-30 row. The RX heading also prints indexed clearance while UCSF uses mL/min.

Before applying: Reconcile the renal metric and endpoint before selecting an interval. Do not choose whichever row is more convenient or merge the label dose range with an institutional interval.

High-dose CRAB treatment is not the routine label regimen

The ID-directed UCSF CRAB regimen can exceed the routine labeled sulbactam exposure. It has different infusion duration and renal eligibility, and its printed extended-infusion columns leave exactly 60 unassigned.

Before applying: Use infectious-disease/antimicrobial-stewardship oversight and the exact infection context. Do not extrapolate this row into unlisted renal or dialysis settings. Keep total combination grams distinct from sulbactam grams.

Also check: UNASYN label and UCSF do not use identical renal bands; High-dose CRAB treatment is not the routine label regimen

Rxlist source

GlobalRPh RX List - Unasyn

Product / population
Adults; IV/IM ampicillin plus sulbactam in the 2:1 ratio. Total-combination grams.
Renal measure
Source table: creatinine clearance mL/min/1.73 m2; accompanying weight-based equation creates a metric ambiguity.

RX mirror: this is not independent corroboration of its underlying label. Check dated-label and formulation limitations.

Renal dosing, restrictions and evidence limits

The adult renal table lists total combination doses of 1.5-3 g every 6-8 hours at clearance at least 30; every 12 hours at 15-29; and every 24 hours at 5-14. Its heading prints mL/min/1.73 m2, while the accompanying estimation formula uses age, weight and serum creatinine; this metric inconsistency needs reconciliation before applying a threshold. Serum creatinine should reflect steady state. A 3-g dose contains 2 g ampicillin plus 1 g sulbactam. The usual label limits sulbactam to 4 g/day. The selected table does not supply a below-5 or dialysis regimen.

Source revision: Source revision date not established in selected retrieval. | Retrieved: 2026-09-07. Retrieval date is not the revision date.

Source: https://globalrph.com/rx-list/unasyn-drug/

Scope: Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph. GlobalRPh v6.6.

Full source card / provenance

All sources, comparison tools and evidence navigation
Source-first renal review

Evidence sources and renal implications

Choose a source to jump directly to its locally stored result. Qualitative precautions and evidence gaps remain visible even when no numerical clearance schedule is supplied.

Read 2 source difference / applicability notes

Preserved GlobalRPh source

Preserved original GlobalRPh source

Preserved historical content; not revalidated as current prescribing guidance.

Renal method: Read the measure and population stated in the original source sections.
Retrieved: 2026-09-05

GlobalRPh RX List

GlobalRPh RX List - Unasyn

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Adults; IV/IM ampicillin plus sulbactam in the 2:1 ratio. Total-combination grams.

Renal method: Source table: creatinine clearance mL/min/1.73 m2; accompanying weight-based equation creates a metric ambiguity.
Retrieved: 2026-09-07

Professional guidance

UCSF - ampicillin/sulbactam

Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.

Renal method: CrCl in mL/min where specified; no equation inferred.
Retrieved: 2026-09-05

Professional guidance

UCSF: ampicillin/sulbactam adult institutional dosing

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Adult institutional antimicrobial dosing; standard and separately ID-directed CRAB pathways.

Renal method: CrCl in mL/min; intermittent versus continuous hemodialysis; source-specific boundaries
Retrieved: 2026-09-07

Source presence is not independent validation. A label mirror is not a second independent source; review the original reference and exact formulation.

Find text within this drug
Find a term without leaving this drug

Search the stored clinical text

Locate a word or phrase within this drug's source summaries. Choose all sources or one source to focus the search. The selection never hides warnings or source text, changes a dose, or proves that a renal finding is absent.

Find:

Enter at least two characters. Searches stay on this page and are not saved or sent.

All source summaries, original wording and provenance
Before applying a renal protocol

Check the setting. Compare whole sources.

No patient-specific dose is calculated. Context choices only display reminders; they do not validate, hide or change any regimen.

Share a reproducible source review

Choose sources below, then open a print-ready comparison with product scope, renal method, dates and cautions. Links can pin the exact local cards; they never contain patient values or choose a dose.

Open / share selected sources

Select two distinct source versions. The complete stored summaries will appear below.

Build a source-review outline for documentation

This creates a blank decision outline with the source identities you select, not a dose recommendation or completed clinical assessment. No patient fields are collected, saved or sent. Complete the clinical decisions in your approved documentation system.

Choose one or two sources above or use the source checkboxes below.

Renal-context checklist: population, kidney trend and dialysis

These prompts are a reading aid, not a prescription checklist or proof that all requirements have been met. No selections are stored or sent to a server.

Read the exact source scope, renal metric and date before selecting a row. No applicability assessment has been performed.

See source-specific renal methods and the clinical interpretation guide for the supporting context.

Read before choosing a regimen

Source differences and product cautions

Search differences across all drugs

These are specific issues found during source review, not an automated judgment that one source is universally correct. A label mirror and its original label are not independent evidence.

renal metric and threshold

UNASYN label and UCSF do not use identical renal bands

At the printed value 30, the RX label table places patients in its at-least-30 row, whereas UCSF standard dosing places 30 in its 15-30 row. The RX heading also prints indexed clearance while UCSF uses mL/min.

How to use this: Reconcile the renal metric and endpoint before selecting an interval. Do not choose whichever row is more convenient or merge the label dose range with an institutional interval.

Source-specific interpretation; independent clinician adjudication pending.

specialist indication regimen

High-dose CRAB treatment is not the routine label regimen

The ID-directed UCSF CRAB regimen can exceed the routine labeled sulbactam exposure. It has different infusion duration and renal eligibility, and its printed extended-infusion columns leave exactly 60 unassigned.

How to use this: Use infectious-disease/antimicrobial-stewardship oversight and the exact infection context. Do not extrapolate this row into unlisted renal or dialysis settings. Keep total combination grams distinct from sulbactam grams.

Source-specific interpretation; independent clinician adjudication pending.

Go directly to the relevant source section

Renal dosing and precautions

Choose a source, then jump to its renal or dialysis section. These links locate stored text; they do not merge regimens or certify that sources agree.

New source summary - independent clinical review pending. Summaries of the identified label sections are included locally. Source import and numeric transcription checks are not independent two-reference validation. Do not treat this card as an approved institutional dosing protocol.

No dialysis or renal heading shown? Read the complete source summary. Absence of a heading is not evidence that dose adjustment is unnecessary.

Compare or copy source versions

All content below is stored locally. Read a whole source version; do not combine its dose with another source's interval, renal metric or dialysis assumptions.

Choose two source checkboxes below.
Historical source content is not a current prescription. Original GlobalRPh recommendations are preserved, not automatically certified as current. Product-label and professional additions below are separately attributed. Confirm indication, population, kidney-function method, monitoring and the full prescribing information before applying a regimen.

Important source distinctions

The source summary and source table use slightly different boundary notation at CrCl 30. The original indexed table heading and accompanying Cockcroft-Gault formula are retained; renal-function normalization must be confirmed before prescribing.

Locally stored source content

Original GlobalRPh protocol

Clinical facts and comments transcribed into a structured reading format. This is not a byte-for-byte HTML archive. Original source: https://globalrph.com/renal/ampicillin-sulb/

Usual Dosing (Adults)

DOSAGE AND ADMINISTRATION

Ampicillin and sulbactam for injection may be administered by either the IV or the IM routes. For IV administration, the dose can be given by slow intravenous injection over at least 10-15 minutes or can also be delivered, in greater dilutions with 50-100 mL of a compatible diluent as an intravenous infusion over 15-30 minutes. Ampicillin and sulbactam for injection may be administered by deep intramuscular injection.

Preparation for Intramuscular Injection - 1.5 g and 3 g Standard Vials:

Vials for intramuscular use may be reconstituted with Sterile Water for Injection USP, 0.5% Lidocaine Hydrochloride Injection USP or 2% Lidocaine Hydrochloride Injection USP. Consult the following table for recommended volumes to be added to obtain solutions containing 375 mg ampicillin and sulbactam for injection per mL (250 mg ampicillin/125 mg sulbactam per mL). Note: Use only freshly prepared solutions and administer within one hour after preparation.

Vial sizeVolume of diluent to be addedWithdrawal volume
1.5 g3.2 mL4 mL
3 g6.4 mL8 mL

There is sufficient excess present to allow withdrawal and administration of the stated volumes.

The recommended adult dosage of ampicillin and sulbactam for injection is 1.5 g (1 g ampicillin as the sodium salt plus 0.5 g sulbactam as the sodium salt) to 3 g (2 g ampicillin as the sodium salt plus 1 g sulbactam as the sodium salt) every six hours. This 1.5 to 3 g range represents the total of ampicillin content plus the sulbactam content of ampicillin and sulbactam for injection, and corresponds to a range of 1 g ampicillin/0.5 g sulbactam to 2 g ampicillin/1 g sulbactam.

The total dose of sulbactam should not exceed 4 grams per day.

Pediatric Patients 1 Year of Age or Older:

The recommended daily dose of ampicillin and sulbactam for injection in pediatric patients is 300 mg per kg of body weight administered via intravenous infusion in equally divided doses every 6 hours. This 300 mg/kg/day dosage represents the total ampicillin content plus the sulbactam content of ampicillin and sulbactam for injection, and corresponds to 200 mg ampicillin/100 mg sulbactam per kg per day.

The safety and efficacy of ampicillin and sulbactam for injection administered via intramuscular injection in pediatric patients have not been established. Pediatric patients weighing 40 kg or more should be dosed according to adult recommendations, and the total dose of sulbactam should not exceed 4 grams per day. The course of intravenous therapy should not routinely exceed 14 days.

In clinical trials, most children received a course of oral antimicrobials following initial treatment with intravenous ampicillin and sulbactam for injection.

GRPH-ampicillin-sulb-01 · Source section: Usual Dosing (Adults)Renal section finder

Renal Dosing

IV:

[CRCL >30]: 1.5-3.0 grams q6-8h

[15-30]: 1.5-3.0 grams q12h

[5-14]: 1.5-3.0 grams q24 hours

In patients with impairment of renal function the elimination kinetics of ampicillin and sulbactam are similarly affected, hence the ratio of one to the other will remain constant whatever the renal function. The dose of ampicillin and sulbactam for injection in such patients should be administered less frequently in accordance with the usual practice for ampicillin and according to the following recommendations:

Creatinine clearance (mL/min/1.73m2)Ampicillin/Sulbactam half-life (hours)Recommended dosage
>=3011.5-3 g q6h-q8h
15-2951.5-3 g q12h
5-1491.5-3 g q24h

When only serum creatinine is available, the following formula (based on sex, weight, and age of the patient) may be used to convert this value into creatinine clearance. The serum creatinine should represent a steady state of renal function.

Males: weight (kg) x (140 - age) / (72 x serum creatinine)

Females: 0.85 x above value

GRPH-ampicillin-sulb-02 · Source section: Renal DosingRenal section finder

Hemodialysis

Hemodialysis: 1.5-3.0 grams q24 hours - give dose after dialysis when patient is being dialyzed.

PD: 1.5-3.0 grams q24 hours

GRPH-ampicillin-sulb-03 · Source section: HemodialysisRenal section finder
Locally imported selected renal sections

GlobalRPh RX List renal information

Rxlist

GlobalRPh RX List - Unasyn

Open original reference

Open / share this exact local source

GlobalRPh-hosted RX List · Adults; IV/IM ampicillin plus sulbactam in the 2:1 ratio. Total-combination grams.

Renal method: Source table: creatinine clearance mL/min/1.73 m2; accompanying weight-based equation creates a metric ambiguity.
Source date: Source revision date not established in selected retrieval.
Retrieved: 2026-09-07

Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.

Renal dosing, restrictions and evidence limits

The adult renal table lists total combination doses of 1.5-3 g every 6-8 hours at clearance at least 30; every 12 hours at 15-29; and every 24 hours at 5-14. Its heading prints mL/min/1.73 m2, while the accompanying estimation formula uses age, weight and serum creatinine; this metric inconsistency needs reconciliation before applying a threshold. Serum creatinine should reflect steady state. A 3-g dose contains 2 g ampicillin plus 1 g sulbactam. The usual label limits sulbactam to 4 g/day. The selected table does not supply a below-5 or dialysis regimen.

RDM36-rxlist-ampicillin-sulb-b783ee53aa-C1 · Source locator: Dosage: adult dose; impaired renal function, Table 3 and following equation.

Source identity and provenance
Source family
product_label_mirror
Source
https://globalrph.com/rx-list/unasyn-drug/
Retrieved
2026-09-07
Renal-function method
Source table: creatinine clearance mL/min/1.73 m2; accompanying weight-based equation creates a metric ambiguity.
Source date/version
Source revision date not established in selected retrieval.
Hash meaning
SHA-256 of local authored summary only; not original HTML, PDF or SPL bytes.
Local summary SHA-256
5b6f307ac63e1a1d110216490465f7f1118d79da582c116bde71364b77cf21de
Separate professional-source layer

University and professional protocols

Professional

UCSF - ampicillin/sulbactam

Open original reference

Open / share this exact local source

UCSF Infectious Diseases Management Program · Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.

Renal method: CrCl in mL/min where specified; no equation inferred.
Source date: Revision date not stated in the reviewed page.
Retrieved: 2026-09-05

Locally included source-specific summary. Regimen differences are not automatically resolved.

Dosing / renal protocol and limits

Standard adult IV dosing: CrCl >30 mL/min, 3 g every 6 hours; 15-30, 3 g every 12 hours; <15, 3 g daily. Intermittent HD: 3 g every 12 hours. Continuous HD: 3 g every 6 hours.

For carbapenem-resistant A. baumannii at CrCl >60, the specialist extended-infusion regimen is 9 g every 8 hours over 4 hours. The source requires ID/pharmacy advice for lower renal function or dialysis in that indication rather than applying the standard-infection table. Exactly 60 is not assigned in the CRAB row.

RDM30-054-ampicillin-sulb-1 · Source locator: UCSF - ampicillin/sulbactam; renal/dosing sections and stated qualifiers

Source identity and provenance
Source
https://idmp.ucsf.edu/content/ampicillin-sulbactam-unasyn
Retrieved
2026-09-05
Renal-function method
CrCl in mL/min where specified; no equation inferred.
Source date/version
Revision date not stated in the reviewed page.
Hash meaning
Locally authored summary text; not original SPL, HTML or PDF bytes
Local summary SHA-256
f577ec3943fdc1568b47035fcd93e59e91ee62d0b6fe68c2af6be17731b6535f
Professional

UCSF: ampicillin/sulbactam adult institutional dosing

Open original reference

Open / share this exact local source

UCSF Infectious Diseases Management Program · Adult institutional antimicrobial dosing; standard and separately ID-directed CRAB pathways.

Renal method: CrCl in mL/min; intermittent versus continuous hemodialysis; source-specific boundaries
Source date: Source revision date not established in selected retrieval.
Retrieved: 2026-09-07

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.

Renal dosing, restrictions and evidence limits

UCSF standard adult IV dosing is 3 g every six hours for CrCl above 30 mL/min, every 12 hours at 15-30, and every 24 hours below 15. Its intermittent-hemodialysis regimen is 3 g IV every 12 hours; continuous-hemodialysis dosing is 3 g IV every six hours. For carbapenem-resistant Acinetobacter baumannii, the separate ID-directed extended-infusion row lists 9 g IV every eight hours over four hours only above CrCl 60; lower categories require ID/antimicrobial-stewardship pharmacy guidance. The printed extended-infusion columns leave exactly 60 unassigned. These are total combination grams. Do not extrapolate the specialized regimen into unlisted renal settings or treat all CRRT prescriptions as identical.

RDM36-professional-ampicillin-sulb-ce3d7082f6-C1 · Source locator: Adult non-dialysis table; extended infusion table; intermittent/continuous dialysis table.

Source identity and provenance
Source family
professional_guidance
Source
https://idmp.ucsf.edu/content/ampicillin-sulbactam-unasyn
Retrieved
2026-09-07
Renal-function method
CrCl in mL/min; intermittent versus continuous hemodialysis; source-specific boundaries
Source date/version
Source revision date not established in selected retrieval.
Hash meaning
SHA-256 of local authored summary only; not original HTML, PDF or SPL bytes.
Local summary SHA-256
02a47c000015b50b1f7cabe0f5d2e34ab1ae88bf171cee5a913c29cead97a6bd

Provenance and preservation

Additional summaries stored on this page: 0 official-label, 1 RX List, 2 professional, 0 handbook. Empty additional-source groups are not shown. A missing layer is not a no-adjustment recommendation.

Original source
https://globalrph.com/renal/ampicillin-sulb/
Source retrieval
2026-09-05. This is not the source publication or label revision date.
Original source type
globalrph individual
Local text SHA-256
66c7cb4823da5434e1eb55c001f9413a6d3184a6ced0e7a43b6cc1c9003f2a8b
Import versus clinical validation
Source-section locators identify where retained content came from. A source-section identifier does not assert that every numeric statement has been independently corroborated. The local text hash is not a hash of original HTML, an FDA PDF or SPL XML.

The original individual GlobalRPh pages commonly cite NIH/NLM DailyMed and instruct readers to review the applicable package insert for updates. That historical reference is preserved as context; it is not counted as an independently retrieved current label.

Read the full coverage report